semi-synthetic cytisine derivatives (Achieve Life Sciences)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namesemi-synthetic cytisine derivatives (Achieve Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors modulators
TargetsNicotinic receptors
Therapy Area/IndicationsTobacco Use DisorderSubstance-Related DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bristol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAchieve Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use DisorderSubstance-Related DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A